These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 24584597)
1. The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis. Stevenson S; Tang W; Cho Y; Mudge DW; Hawley CM; Badve SV; Johnson DW Perit Dial Int; 2015; 35(2):222-8. PubMed ID: 24584597 [TBL] [Abstract][Full Text] [Related]
2. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes. Blunden M; Zeitlin D; Ashman N; Fan SL Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615 [TBL] [Abstract][Full Text] [Related]
3. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry. Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475 [TBL] [Abstract][Full Text] [Related]
4. Serum vancomycin levels predict the short-term adverse outcomes of peritoneal dialysis-associated peritonitis. Ma Y; Geng Y; Jin L; Wang X; Liang C; Xie L; Lu W; Lv J Perit Dial Int; 2023 Jan; 43(1):37-44. PubMed ID: 35021905 [TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Govindarajulu S; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW Perit Dial Int; 2010; 30(3):311-9. PubMed ID: 20190031 [TBL] [Abstract][Full Text] [Related]
6. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Barraclough K; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW Am J Kidney Dis; 2010 Jan; 55(1):121-31. PubMed ID: 19932543 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW Perit Dial Int; 2017; 37(6):619-626. PubMed ID: 28698253 [TBL] [Abstract][Full Text] [Related]
8. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391 [TBL] [Abstract][Full Text] [Related]
9. The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Tang W; Cho Y; Hawley CM; Badve SV; Johnson DW Perit Dial Int; 2014; 34(2):219-26. PubMed ID: 24385334 [TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study. Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794 [TBL] [Abstract][Full Text] [Related]
11. Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Edey M; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW Nephrol Dial Transplant; 2010 Apr; 25(4):1272-8. PubMed ID: 19948875 [TBL] [Abstract][Full Text] [Related]
12. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Fahim M; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW Am J Kidney Dis; 2010 Apr; 55(4):690-7. PubMed ID: 20110144 [TBL] [Abstract][Full Text] [Related]
13. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients? Kan GW; Thomas MA; Heath CH Perit Dial Int; 2003; 23(5):465-8. PubMed ID: 14604199 [TBL] [Abstract][Full Text] [Related]
18. Linking clinical manifestations and causative organisms may provide clues for the treatment of peritoneal dialysis-associated peritonitis. Ren DD; Pan YJ; Nie JD; Wang X; Tang W BMC Nephrol; 2024 Sep; 25(1):322. PubMed ID: 39334001 [TBL] [Abstract][Full Text] [Related]
19. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges. Shah KJ; Cherabuddi K; Pressly KB; Wright KL; Shukla A BMC Nephrol; 2020 Mar; 21(1):76. PubMed ID: 32131755 [TBL] [Abstract][Full Text] [Related]
20. Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study. Burke M; Hawley CM; Badve SV; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Johnson DW Am J Kidney Dis; 2011 Sep; 58(3):429-36. PubMed ID: 21601333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]